Rocket Pharmaceuticals (RCKT) Shares Outstanding (2014 - 2026)

Rocket Pharmaceuticals has disclosed Shares Outstanding across 13 years of filings, most recently posting $109.1 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $109.1 million, up 2.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $109.1 million (up 2.22% YoY), and the FY2025 annual result was $108.3 million, up 1.75% from the prior year.
• Shares Outstanding came in at $109.1 million for Q1 2026 at Rocket Pharmaceuticals, up from $108.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $109.1 million in Q1 2026 to a low of $64.5 million in Q1 2022.
• The 5-year median for Shares Outstanding is $90.6 million (2024), against an average of $90.5 million.
• Across the five-year window, Shares Outstanding soared 32.88% in 2023 and advanced 1.08% in 2024, its largest moves.
• Rocket Pharmaceuticals' Shares Outstanding stood at $79.1 million in 2022, then grew by 14.1% to $90.3 million in 2023, then advanced by 17.91% to $106.5 million in 2024, then increased by 1.75% to $108.3 million in 2025, then increased by 0.74% to $109.1 million in 2026.
• The last three Shares Outstanding figures came in at $109.1 million (Q1 2026), $108.3 million (Q4 2025), and $108.2 million (Q3 2025), per Business Quant data.